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Abstract 
Cognitive impairment is common and associated with poor quality of life after stroke 
and therefore, an important target for rehabilitation. Cognitive impairment can also 
be an obstacle to rehabilitation of movement and other functions, given that current 
approaches often engage learning mechanisms. Cognitive function was identified as 
an important, but relatively neglected target during the first Stroke Recovery and 
Rehabilitation Roundtable (SRRR I) and a Cognition Working Group was convened 
as part of SRRR II. There is currently insufficient evidence to build consensus on 
specific approaches to cognitive rehabilitation. However, consideration of cognition in 
recovery studies more broadly is important. We present recommendations on the 
integration of cognition into stroke rehabilitation studies generally and define 
priorities for ongoing and future research in the field of stroke recovery and 
rehabilitation. A number of promising interventions are ready to be taken forward to 
trials to tackle the gap in evidence for cognitive rehabilitation and some of the most 
promising of these approaches are discussed as part of mapping future directions for 
cognitive recovery research.  
 
  
Background 
Epidemiology and Importance 
SRRR I1  focussed on motor recovery since it was most developed in terms of 
mechanistic understanding and readiness for clinical trials. Cognitive function 
was not considered in SRRR I but was identified as a future priority. The definition 
of post-stroke cognitive impairment that we use here is a new cognitive deficit that 
develops in the first 3 months following stroke onset and persists for a minimum 
duration of six months from outset, which is not explained by any other condition or 
disease, e.g. metabolic and endocrine disorders, or depression13. 
Neuropsychological testing 3 weeks after stroke reveals cognitive deficits in 30-
40% of individuals2, across a broad range of domains such as executive function, 
visuospatial cognition, episodic and working memory3. Furthermore, cognitive, 
affective and behavioural consequences of stroke are more strongly associated 
with quality of life than measures of physical disability4. The risk of dementia after 
stroke is high, with a post-event incidence of 34% one year after either stroke or 
TIA5. Stroke survivors highlight cognitive disturbance as an area of unmet need: 
difficulties with memory, concentration and fatigue were the leading areas 
reported as unmet needs in the UK Stroke Survivor Survey6. Existing 
international guidelines for stroke rehabilitation highlight the lack of evidence for 
specific approaches for rehabilitation of cognitive function7, so defining priorities 
to fill gaps in existing evidence was a major element of the SRRR II effort to 
generate research alignment.  
 
Mechanisms of Impairment and Recovery 
Cognitive function relies on effective signalling between cortical and subcortical brain 
regions. Lesions may disrupt network structure and function by direct or indirect 
injury to grey matter regions or white matter connections that form cognitive 
networks. Secondary mechanisms of injury include degeneration of connected 
structures and secondary injury that results from the cascade of pathological events 
triggered by strokes such as, reactive astrogliosis, infiltration of immune cells, and 
activation of programmed cell death. Alterations in structural connectivity can be 
evaluated non-invasively by diffusion MRI, or invasively (in animal models) using 
neuroanatomical tracing. Functional connectivity can be measured with 
electrophysiological approaches including EEG/MEG and functional MRI. Cognitive 
impairments are in part mediated by changes in functional connectivity, as has been 
shown for frontal brain regions that are involved in executive function8. Whilst there 
are available methods to assess structural and functional connectivity changes after 
stroke, longitudinal studies are needed to fully understand the evolution of post-
stroke cognitive impairment.  
 
Mechanisms of recovery are likely to include synaptic and experience-dependent 
plasticity of damaged and undamaged circuits11, which supports the acquisition of 
new cognitive skills. Neurogenesis is now thought to occur throughout adult life and 
is also implicated in some aspects of cognition9. The role of neurogenesis in 
cognitive recovery after stroke remains unknown, but immature neurons migrate to 
sites of ischaemic injury10. The potential role of immune and glial cells in recovery of 
function is also an area of active interest, with chronic reactive astrogliosis in white 
matter tracts linked to delayed impairment in memory.  
 
Challenges in Recovery and Rehabilitation Research 
Cognition is multi-dimensional. The DSM-5 approach to neurocognitive disorders 
recognises six major domains, each having multiple subdomains12. A proper account 
of the consequences of damage to specific domains requires an understanding of 
the distributed neural networks that span cortical and subcortical structures that 
underpin the neurocognitive domains (Figure 1). As a consequence, at the typical 
spatial scale of stroke, multiple networks are affected to varying degrees. This 
heterogeneity, along with a vast range of approaches for testing cognition, creates 
difficulties in defining consistent measurement approaches for use in rehabilitation 
trials. The vast array of cognitive testing approaches is replicated in behavioural 
paradigms for animal model research. Additionally, cognitive impairments can be 
delayed and, acutely, apparent impairments can be exaggerated by systemic factors, 
such as acute infection and delirium. Another complicating factor is the lack of 
information on pre-morbid cognitive status.  
 
Context and Scope 
The SRRR meetings have been firmly anchored around recovery from stroke, as a 
discrete clinical event defining the start of a period for rehabilitation. Previous studies 
adopt a design that included stroke as an index event, such as studies of cognition in 
hospital-based cohorts or studies in a stroke rehabilitation setting.  
 
There have been a number of initiatives to develop consistency of approach and 
consensus in relation to clinical entities that overlap or can co-exist with acute stroke, 
such as cerebral small vessel disease and vascular cognitive impairment (VCI)14. 
More recently, the Vascular Impairment of Cognition Classification Consensus 
Study15 agreed on guidelines for diagnosis and reiterated support for standardised 
neuropsychological and imaging approaches, previously proposed by the National 
Institute of Neurological Disorders and Canadian Stroke Network (the VCI 
Harmonization Standards16). A recent UK initiative is seeking to build consensus 
around functional assessment for animal models of VCI17. Efforts to drive research 
alignment in VCI are relevant to the Cognition theme of SRRR II and share features, 
notably the emphasis on translation and new therapies. The SRRR II Cognition 
Working Group was focussed primarily on the setting of stroke rehabilitation, and 
rehabilitation trials. Aspects of VCI other than acute stroke, such as silent infarction 
or insidious small vessel disease, were not within the group’s scope. 
 
Developing interventions that interfere with mechanisms of delayed injury or 
enhance intrinsic mechanisms of neural adaptation is at the heart of rehabilitation 
research. Animal models provide a means to explore basic mechanisms and 
possible interventions. The two-way interaction between preclinical and clinical 
research was therefore viewed as central to cognitive recovery research and a core 
component of the working group’s mission. The group sought to make 
recommendations that span preclinical and clinical research and that will foster more 
effective translation.  
  
Methods and Participants 
The Cognition Working Group gathered experts from a diverse range of fields. A 
group (n=7) met in person at the SRRR II meeting in Saint-Sauveur, Canada in 
October 2018. A wider advisory group was also established to provide additional 
expertise. Overall, expertise in clinical stroke, rodent models of stroke, neuroimaging 
of humans and animal models, neuropsychology, including cross-species 
approaches, the neurobiology of language and cognitive rehabilitation were 
represented.  
 
In advance of SRRR II, a structured survey was sent to the participants and from 
this, a list of the major challenges in cognition in relation to stroke recovery and 
rehabilitation was defined, and an agenda formed for the working group meeting. In 
a number of areas, it was recognized that there was inadequate evidence to support 
alternative approaches to develop consensus. In these areas, the methodology 
shifted to definition of the major priorities for research in post-stroke cognition. 
 
Cognition in Rehabilitation Research: Generic Recommendations  
An essential aspect of function to be incorporated into the design of a stroke 
rehabilitation study might be defined as one that: is likely affected by stroke; is 
sensitive to therapy; and has importance relative to overall outcome. Therapeutic 
approaches are often not specific to motor function (e.g. systemically administered 
drugs) so that cognitive improvement may be part of a therapeutic effect. 
Furthermore, cognitive impairment is an important determinant of quality of life after 
stroke. Therefore, the collective view was that cognitive function meets the criteria to 
be evaluated in all trials and observational studies of stroke recovery. This should 
include assessment of cognition at entry and as an outcome measure. The need to 
develop recommendations for outcome measurements of cognition for stroke trials is 
something that was recognised during the SRRR in 201618. The Montreal Cognitive 
Assessment is currently the most extensively evaluated, in terms of sensitivity and 
cultural validity, but alternatives are needed. A separate working group is currently 
undertaking a prioritisation method using Value Focused Thinking Methodology to 
rank the psychometric properties of cognitive screening tools against pre-determined 
desirable properties of measurement tools, across stroke recovery time points 
(acute, sub-acute and chronic).  
 
The systematic exclusion of patients with aphasia from recovery studies was 
identified as a major concern, both in terms of generalisability and equitable access 
to treatments that are shown to work in non-aphasic individuals. A consensus 
recommendation of the group is that a scientifically robust approach is required to 
participant selection on this basis (Table 1). 
 
Research Priorities: Enhancing the translational potential of preclinical 
cognitive recovery research 
Most preclinical stroke recovery research has focussed on the motor system. This 
work has identified critical periods of sensorimotor recovery and cellular mechanisms 
that govern neural repair following stroke10, 19. Previous consensus 
recommendations for the alignment of preclinical and clinical stroke recovery 
research from SRRR I focussed on sensorimotor recovery, although many of these 
guidelines could be applied to cognitive recovery. The recommendations 
emphasised the importance of using sensitive outcome measures that are in close 
association with human stroke to best capitalise on the potential of experimental 
models.  
 
Traditionally, research has utilised models such as the middle cerebral artery 
occlusion (MCAo) model, which have limited value for studying cognition as the 
injury primarily impacts sensorimotor circuits. Greater priority should be given to 
replicating behavioural impairments observed in the clinical setting using 
photothrombosis, endothelin-1, and microvascular emboli models that can produce 
targeted damage to brain regions, with no (or limited) motor deficits. Additionally, 
efforts should be made to employ models that exhibit cognitive deficits in a variety of 
domains, particularly higher-order processes commonly impacted in human stroke 
(e.g. attention, executive function, speed of processing, dual-tasking, and cognitive 
flexibility). These domains can be examined in the rodent; however, few preclinical 
stroke models have employed such measures, with studies largely focussing on 
using relatively easy to study spatial memory deficits (e.g. Morris water maze, Radial 
arm Maze, etc.), which are not dramatically impacted by MCAo. While traditional 
paradigms to assess cognition still have merit, greater emphasis should be placed 
on cognitive tasks that directly translate across species (Table 2). This may be 
achieved through utilisation of new technologies, such as touch-screen tablets, that 
allow the delivery of testing paradigms in rodents that mirror the conditions that 
humans would also be tested under20, 21. It can be argued that a significant 
component of stroke rehabilitation is relearning of many tasks of daily life; therefore, 
preclinical studies should consider the addition of relearning paradigms in their 
experiments. We also know that cognitive deficits following a discrete and identifiable 
stroke do not occur in isolation and may be modulated by underlying cognitive risk 
factors. Therefore, preclinical studies should also incorporate increasing age, 
cardiovascular and metabolic comorbidities (diabetes, diet, etc.), and microvascular 
injury.   
 
There are a number of ways in which preclinical research can significantly contribute 
to our understanding of post-stroke cognitive recovery. Effort should be made to 
monitor longer-term behavioural changes to reflect chronicity and progressive 
decline in cognitive function, in combination with structural and functional changes in 
neural networks (histology, in vivo neuroanatomical tracing, MRI, electrophysiology), 
in an attempt to identify important epochs and markers of cognitive recovery. In 
addition, the preclinical environment can serve as a fertile testing ground for 
validation of novel therapeutic strategies prior to translation to the clinical setting. To 
maximise the chance of translation, adoption of a level of rigour equivalent to clinical 
trials in humans is required, including randomisation, blinding and reporting 
standards. Specific to cognitive function, this includes rigorous standards for 
selection, execution and reporting of cognitive test paradigms. Preclinical 
researchers require training and expertise to properly conduct cognitive tests, and 
experimental procedures should be reported in detail20. 
 
Research Priorities: Translational and Clinical Research  
Recovery epochs, Therapeutic Windows and Biomarkers 
The cellular and biochemical changes triggered by stroke include both early and late 
events that occur both proximal and distal to the site of injury. This heterogeneity 
suggests that there may be distinct epochs of recovery. The notion of recovery 
epochs dominated by one or several cellular or biochemical mechanisms 
emphasizes the challenge of correct timing of interventions in trials.  
 
One consensus conclusion was that epochs need to be defined mechanistically 
because mechanistic understanding defines candidate therapies. However, much 
more data is needed. Major gaps include the lack of detailed longitudinal studies 
using imaging (structural and functional MRI) and other biomarkers in humans, and a 
relative paucity of long-term follow up data in animals after stroke. Biomarkers 
provide promising avenues for the definition of epochs, with the potential to span 
clinical and preclinical models. For example, PET ligands can track microglial 
activation along white matter pathways after stroke and label biochemical hallmarks 
of late neurodegeneration, such as amyloid and tau deposition. Refining definitions 
of post-stroke cognitive impairment based on biomarkers would parallel the use of 
biomarkers in recent approaches to the diagnosis of Alzheimer’s Disease. 
 
Premorbid Function and Functional Reserve 
Pre-stroke cognitive performance is thought to influence cognitive outcome after 
stroke, including the risk of developing future dementia. However, accurate 
ascertainment of premorbid ability is challenging and contemporary approaches are 
limited to methods to infer past performance based on patient and carer responses 
to questions asked after stroke. There is no validated method to assess cognitive 
reserve and predict its influence on rehabilitation trajectory. Multivariate approaches 
to neuroimaging data are beginning to reveal information about overall brain status, 
such as methods to infer “brain age”. Application in a stroke rehabilitation setting is, 
however, complicated by the fact that structural and functional alterations after stroke 
are known to extend well beyond sites of visible infarction. 
 
Integration of Patient and Carer-reported Outcome Measures 
Much attention has focussed on defining optimal objective testing approaches to 
measure post-stroke cognitive impairment, primarily based on trying to capture 
typical patterns of cognitive impairment. However, more work is required to link this 
approach to stroke outcome as defined by patients, relatives and carers. 
Understanding the associations of cognitive function with quality of life after stroke is 
essential both in setting research priorities – across the translational spectrum – and 
defining the health economics benefits of new interventions to enhance cognitive 
recovery after stroke. Technology provides new opportunities for integration of 
objective, patient and carer-reported outcome measures. For example, tablets and 
smartphones can deliver cognitive tests and prompt reporting of status by patients 
and carers. Wearable devices can provide information on natural behaviour 
(locomotion) and information about factors that modulate cognitive performance, 
such as sleep. The integration of patient- and carer-reported and technology-derived 
information with more traditional evaluation of cognition presents a major opportunity 
for recovery research, with particular relevance for cognition. 
 
Candidate Therapies for Cognitive Rehabilitation 
The approaches we are interested in directly target cognitive impairments 
themselves (e.g. executive functions) and not aids (e.g. pagers, reminders) that 
improve patients’ real-world functioning, but not by directly changing cognitive 
processing (when the aid is removed, its therapeutic effects are suddenly lost). 
There are several detailed reviews relating to this topic22, 23, so here we confine 
ourselves to outlining some of the key issues. Firstly, it is difficult to isolate individual 
cognitive functions in terms of measuring outcomes (e.g. working memory and 
attention frequently modulate tests of executive function). One promising approach 
that also does away with the issue of correcting for multiple comparisons across 
tests that are somewhat collinear, is to perform an omnibus test on two different sets 
of outcomes; those that represent a range of executive functions and those that do 
not (e.g. are more sensitive to posterior cortical functions). Love et al. did just this 
using a Bayesian approach24. Secondly, interventions need to be delivered in high 
enough doses to maximise the likelihood of clinically meaningful gains. A way to do 
this is to augment therapist-delivered, face-to-face training with digital therapies. This 
has been carried out successfully in studies designed to improve: working memory25; 
goal processing and sustained attention26; and, real-world problem solving, with 
promising effect sizes27. Thirdly, with respect to generating evidence from animal 
models that will be relevant for human rehabilitation, some aspects of cognition are 
easier to study than others. For example, there are good measures of working 
memory and attention (Table 2) but less analogous ones for complex decision 
making. While not all cognitive interventions and tests currently have direct 
equivalents in animal models, there are synergies in cellular and genetic 
mechanisms that mediate higher cognitive functions across species. For example, 
changes in the tonic GABA inhibitory pathway have been implicated in age-related 
decline of human memory function, including spatial reference and working 
memory28. Stroke induces an elevation in tonic GABA signaling and compounds that 
dampen this response have shown promise in animal models for motor recovery and 
are currently being tested in a Phase II trial (ClinicalTrials.gov ID; Servier RESTORE 
BRAIN Study - NCT02877615). These compounds have also been recently tested in 
a preclinical model of VCI and shown to improve both reference and working 
memory. and there is evidence that GABAergic drug therapy improves some of the 
attentional and cognitive symptoms of Fragile X-syndrome29. Similarly, Brain Derived 
Neurotrophic Factor (BDNF) has been implicated as mediating improved spatial 
memory in a trial of aerobic exercise training in older adults, where training increased 
hippocampal volume, effectively reversing age-related loss by 1 to 2 years30. A 
recent phase II clinical trial in patients with post-stroke cognitive impairment, showed 
that exercise paired with cognitive training did improve fluid intelligence, but the 
relationship to BDNF was less clear31. It is here that animal models provide a much 
more fine-grained approach to understanding the intricacies of the cellular and 
genetic substrates that underpin human cognition32. Armed with such an 
understanding, we will be in a better position to test interventions in rehabilitative 
studies in patients. 
 
Conclusions 
Research on cognitive recovery after stroke is at an earlier stage of evolution than 
research in motor recovery. Nevertheless, international consensus is possible in a 
number of areas. All stroke recovery studies should consider cognition and integrate 
cognitive evaluation and outcome into their design. Basic neuroscience is essential 
to develop new interventions to enhance recovery. In order to achieve this, greater 
alignment between preclinical and clinical research – and the development of an 
agenda of shared priorities – is required to accelerate progress towards novel 
therapies. This is best achieved using a bedside to bench to bedside approach.  
  
Table 1. Consensus Recommendations 
Recommendations: Observational Studies and Trials 
 
 
 
 
 All intervention studies and trials should include evaluation of 
cognition 
 
 Cognitive function should be evaluated at study enrolment 
and as an outcome measure (secondary if not primary) 
 
 Wherever possible, studies should include evaluation of other 
behavioural aspects that are associated with cognition and 
important for quality of life: e.g. mood, apathy, fatigue, 
anxiety, sleep. 
 
 Selection of participants based on language should utilise a 
formal assessment of language function, apply clear exclusion 
criteria and aim to define a minimum scientifically justified 
rate of exclusion 
 
 
 
Developmental Priorities 
 
 
 
 
 
 Longitudinal studies of cognition, with long follow up periods, 
in clinical and preclinical research 
 
 Identification of biomarkers for processes and epochs of 
recovery (identification of targets for intervention) 
 
 Greater use of cognitive paradigms that translate between 
clinical and preclinical research (supported by standards for 
selection, execution and reporting of tests) 
 
 
 
 
Table 2. Cognitive paradigms and translation from models to humans 
Neurocognitive 
Domain (DSM-5) 
Subdomain Human Paradigm Preclinical Paradigms  Comments  
Executive 
function 
 
Cognitive flexibility Wisconsin Card 
Sorting Test 
Digit Symbol 
Substitution33 
Attention set-shift  
 Inhibition/impulsivity Go no-go tasks  Operant conditioning  
 Working memory Digit Span 
Spatial Span 
T-maze (Delayed 
alternation task) 
Y-maze 
Radial 8-arm maze 
Morris water maze 
Trial-unique delayed 
non-matching-to-
location (TUNL) task 
 
Tasks of spatial working memory 
translate more easily between 
humans and models. There are 
many paradigms that have been 
studied extensively in humans. 
Despite this, clinical studies 
currently often opt for digit or 
letter span tasks. 
Complex 
Attention 
Sustained Attention Choice Reaction 
Time34, 35 
5-choice serial 
reaction time task36  
5-choice continuous 
performance test  
Signal detection task 
Cross-modal stimulus 
presentations 
 
 Speed of processing Reaction time tasks 5-choice serial reaction 
time task 
 
 Divided attention Walking while counting 
backward 
Unclear whether tested 
in preclinical models 
 
 Neglect Cancellation tasks37 
Line bisection 
 
Adhesive strip removal  While the adhesive removal test 
can assess sensory neglect it is 
a combination of cognitive and 
motor. 
While cancellation tasks have 
used letters, other versions use 
simple objects, such as stars, 
would more easily translate 
between models and humans. 
 
Language    Likely cannot be addressed in 
preclinical animal models 
 
Perceptual-
Motor Function 
Object recognition 
(agnosia) 
Visual discrimination 
Pattern recognition 
Pairwise/Visual 
Discrimination/Reversal 
tasks 
 
 
Learning and 
Memory 
Recognition Delayed non-
matching to sample 
 
Scene Recognition38, 39 
Delayed non-matching 
to sample 
 
 
 Spatial Memory Morris Water Maze 
(human adaptation)* 
 
Morris Water Maze Tests of verbal recall are 
common in human studies, but 
less well-suited than spatial, 
object-based or perceptual tasks 
to translation 
 Associative Learning Paired Associate 
Learning 
 
Object-in-Scene 
memory 
 
Paired Associate 
Learning 
 
Object-in-Scene 
memory 
 
 
 
 Emotional Memory  Fear conditioning  
 
Social Cognition  Little studied in post 
stroke setting 
Not tested in preclinical 
stroke models 
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